van Monsjou H S, Schaapveld M, Hamming-Vrieze O, de Boer J P, van den Brekel M W M, Balm A J M
Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands; Department of Head and Neck Oncology and Surgery, The Netherlands.
Department of Psychosocial Research, Epidemiology and Biostatistics, The Netherlands; Department of Comprehensive Cancer Center Netherlands, The Netherlands.
Oral Oncol. 2016 Jan;52:37-44. doi: 10.1016/j.oraloncology.2015.10.013. Epub 2015 Nov 6.
To assess cause-specific mortality in a large population-based cohort of 14,393 patients treated for squamous cell carcinoma of the oral cavity (OC) or oropharynx (OP) in The Netherlands between 1989 and 2006.
Causes of death were obtained for 94.7% of 9620 patients who had died up to January 1, 2009. We assessed standardized mortality ratios (SMR) and absolute excess mortality (AEM), comparing observed cause-specific mortality with expected mortality for our cohort based on general population mortality rates.
Median survival was 3.9 years. Overall, the study population experienced a 6-fold higher (95% Confidence Interval (95% CI) 5.9-6.1) mortality risk compared with the general population. After three years, 41% of OP and 29% of OC patients had died due to cancer of the oral cavity and pharynx. Additionally, OC and OP patients experienced high excess mortality from esophageal (SMR 10.6 and 17.9) and lung cancer (SMR 4.6 and 6.3). With regard to non-cancer deaths, the highest AEMs were due to diseases of the circulatory system, with OC patients experiencing an AEM of 11.3 per 10,000 person-years for ischemic heart disease. OP patients experienced excess mortality due to pneumonia (AEM 22.1 per 10,000 person-years). The risk of death due to diseases of the digestive system was for OP and OC patients where about equal (AEM 28.7 and 23.80, respectively). The SMR for death due to pneumonia was more than two times higher (4.4 vs. 1.7) for OP patients than for OC patients (P<0.001). From 15 years after diagnosis, second tumors located outside the head and neck region accounted for most of the excess mortality.
Excess mortality in OC and OP patients appears to be dominated by effects of heavy tobacco and alcohol use with high AEM due to second tumors, respiratory, cardiovascular and gastrointestinal diseases. Patients with OP experienced more than two times higher risk of death due to pneumonia than OC patients. Therefore, awareness of this potential complication should be raised along with development of prevention strategies.
评估1989年至2006年期间在荷兰接受口腔鳞状细胞癌(OC)或口咽癌(OP)治疗的14393名基于人群的大型队列患者的特定病因死亡率。
截至2009年1月1日,在9620名死亡患者中,94.7%的患者死因已明确。我们评估了标准化死亡率(SMR)和绝对超额死亡率(AEM),将观察到的特定病因死亡率与基于一般人群死亡率的队列预期死亡率进行比较。
中位生存期为3.9年。总体而言,研究人群的死亡风险比一般人群高6倍(95%置信区间(95%CI)5.9 - 6.1)。三年后,41%的OP患者和29%的OC患者死于口腔和咽癌。此外,OC和OP患者因食管癌(SMR分别为10.6和17.9)和肺癌(SMR分别为4.6和6.3)的超额死亡率也很高。关于非癌症死亡,最高的AEM是由于循环系统疾病,OC患者因缺血性心脏病的AEM为每10000人年11.3。OP患者因肺炎的超额死亡率较高(AEM为每10000人年22.1)。OP和OC患者因消化系统疾病的死亡风险大致相等(AEM分别为28.7和23.80)。OP患者因肺炎死亡的SMR比OC患者高出两倍多(4.4对1.7)(P<0.001)。诊断后15年起,头颈部区域以外的第二肿瘤占大部分超额死亡率。
OC和OP患者的超额死亡率似乎主要由大量吸烟和饮酒的影响所致,因第二肿瘤、呼吸、心血管和胃肠道疾病导致的AEM较高。OP患者因肺炎死亡的风险比OC患者高出两倍多。因此,应提高对这种潜在并发症的认识,并制定预防策略。